Dosidal · Italy
it:authorisation:045183
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Italy |
|---|---|
| Record | it:authorisation:045183 (version 1) |
| Level | authorisation |
| Pack code | not anchored |
| Identifiers | aic-medicine: 045183 |
| Source authority | AIFA |
| Read date | |
| identity | atc: A10BD19 holder: BOEHRINGER INGELHEIM INTERNATIONAL GMBH medicine: GLYXAMBI medicine_code: 045183 procedure: Procedura Centralizzata substances: EMPAGLIFLOZIN/LINAGLIPTIN state: current · read 2026-11-15T12:14:32Z · source: AIFA (open data) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53e7-FnKmBgt129xnXjxSKuEgBlrjnfxJUmocrLA39ZgFGs9TyXM5UuEXe8InfRu2C6mJatN3Nbu03C8s8KamXuAVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |
JSON: https://dosidal-api.ai/v1/records/it:authorisation:045183 · Related records in other markets · Dosidal